We advise medical device boards and leadership teams on where to invest, what evidence to build and how to plan for adoption. Our work connects portfolio strategy with clinical and economic value, market access and the commercial choices that shape growth.
Compare market attractiveness, unmet needs, competitive dynamics and portfolio fit. Decide which products, indications and geographies merit investment, and where to partner, defer or exit.
The output: Portfolio investment paper and market-priority scenarios.
Identify the clinical, economic and usability evidence each decision-maker needs. Connect evidence gaps to commercial priorities and establish what requires validation before investment, market entry or launch.
The output: Evidence strategy and decision-linked gap assessment.
Connect clinical and economic value to the requirements of clinicians, hospital buyers and payers. Assess access barriers, pricing logic and funding assumptions before committing to a market.
The output: Market-access strategy, value proposition and pricing scenarios.
Determine where to launch, which customers to prioritize and what could prevent adoption. Challenge readiness across positioning, evidence, buying pathways, clinical education and commercial capabilities.
The output: Launch strategy, readiness assessment and adoption roadmap.
Evaluate sales channels, account coverage and business models as products mature. Compare capital equipment, disposables and service economics, including the implications of robotics and AI-enabled products.
The output: Commercial-model options and lifecycle growth plan.
We work alongside qualified clinical, regulatory and market-access teams. Clinical care, study execution and formal submissions remain within their specialist remit.
Three stages, scoped at the outset. Start with a focused review or retain us through execution.
Agree the investment or commercial question, available evidence and constraints.
Examine market, clinical and economic assumptions with your qualified specialist teams.
Recommend priorities, decision gates and a roadmap for leadership review.
Strategy informed by the realities of medical technology: clinical evidence, hospital economics and product adoption. Capital equipment, disposables, robotics and AI-enabled products.
Start with the portfolio, evidence or market decision your leadership team needs to resolve.